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Education and debate
Reducing maternal mortality in the developing world:
sector›wide approaches may be the key
Elizabeth Goodburn, Oona Campbell
Reducing “the rate of maternal mortality by 75% by
2015” is one of the development targets that has been
endorsed at numerous international meetings.1 This
target was selected because maternal ill health is the
largest contributor to the disease burden affecting
women in developing countries; because the lifetime
risk of maternal death is much greater in the poorest
countries than in the richest (1 in 12 for women in east
Africa compared with 1 in 4000 in northern Europe);
and because interventions are cost effective (costing £2
($3) per woman and £153 ($230) per death averted).2–5
Preventing maternal deaths: what works?
The technical interventions needed to prevent
maternal deaths are well understood.6 Traditional
maternal and child health interventions, such as
providing antenatal care and training traditional birth
attendants, have failed.2 7 The availability, accessibility,
use, and quality of essential obstetric care for life
threatening conditions, including complications after
abortion, need to be improved (box).2 6 7 What is less
clear is how an environment can be created to enable
interventions to be made in settings with few
resources.8
Creating a functioning health system is the most
obvious means of providing this type of environment.
Most of the resources needed to improve essential
obstetric care exist as integral parts of district health
systems, even if some of the parts do not function well
or need updating (fig 1). In a functioning district health
system the availability, accessibility, use, and quality of
essential obstetric care are expected to be high and
maternal mortality is expected to be low. Some
developing countries, such as China, Sri Lanka, and
Malaysia, have reduced maternal mortality dramati›
cally after improving the coverage and quality of their
health services.8 Conversely in Zimbabwe the progres›
sive erosion of the general standard of health services
has been associated with rising maternal mortality.9
Maternal mortality has been proposed for use as an
indicator of accessible and functional health services.10
The launch of the Safe Motherhood Initiative by
the Interagency Group on Safe Motherhood offers real
opportunities for countries to make progress in
providing effective health care especially if the initiative
is linked to financial support mechanisms designed to
improve the quality of the health sector as a whole.
Causes of maternal deaths
Severe bleeding 25%
Indirect causes including anaemia, malaria, 20%
heart disease
Infection 15%
Unsafe abortion 13%
Eclampsia 12%
Obstructed labour 8%
Other direct causes including ectopic pregnancy, 8%
embolism, or complications of anaesthesia
Summary points
Reducing maternal mortality in developing
countries is an international priority
Preventing maternal deaths requires a functioning
health system
Sector›wide approaches allow donors to support
improvements in health systems
Sector›wide approaches offer the opportunity to
make a sustainable impact on maternal mortality
Improvements in maternal health can be used to
measure the performance of sector›wide
approaches
Components of essential obstetric care
There should be:
• Parenteral antibiotics, oxytocics, and anticonvulsants
available
• Facilities for manual removal of the placenta if
necessary
• Facilities for removal of retained products of
conception if necessary
• Assisted vaginal delivery (for example, using vacuum
extraction) available
• Facilities for blood transfusion
• Facilities for caesarean section
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How can activities to improve maternal
health be supported?
Governments and donors have three main options for
funding large scale activities aimed at improving mater›
nal health: they can take a vertical project approach, a
reproductive health programme approach, or a sector›
wide approach (table). All three approaches present
opportunities and risks.
Vertical maternal health projects
Vertical funding, especially of pilot projects, has several
advantages. The logic of doing a few things well rather
than many things badly is undeniable. Visible short
term gains from intensive, focused activity show that
improvements are possible and create positive
attitudes towards improving services on a wider scale.
Also, the creation of visible links between resources
from donors and improvements in service encourages
continued funding by donors. However, the litany of
adverse effects of vertical financing is familiar to
anyone who has worked at district level in a developing
country. For example, providers often must complete
multiple forms each month, some vehicles can only be
used for transporting people with specific health prob›
lems, or condoms can only be distributed to prevent
AIDS. Similarly, sustainability is frequently mentioned
in policy documents about vertical projects, but in real›
ity most government personnel and, more importantly,
project staff are focused on the immediate perform›
ance of the project and may be reluctant to sacrifice
immediate results for longer term gains. Thus,
improvements resulting from vertical approaches may
raise expectations while undermining the overall
system.
Despite the drawbacks of vertical funding, many
safe motherhood projects initiated in the past few
years, which include British funded projects in Malawi
and Nepal and projects funded by the United States in
Indonesia, Guatemala, Morocco, and Egypt, exhibit a
number of vertical design features. However, the safe
motherhood concept will almost certainly never attract
the funds required to set up completely vertical and
parallel health systems, and indeed this has never been
proposed. Thus, despite having vertical design features
these projects typically rely on government health
infrastructure and health personnel and have been
hampered by sector›wide deficiencies including the
poor performance of health staff which is associated
with low pay and adverse working conditions.
Reproductive health programmes
The integrated funding of reproductive health
programmes is often proposed as an alternative to the
vertical funding of essential reproductive health activi›
ties. The central role of safe motherhood programmes
within such reproductive health programmes was sup›
ported within the plan of action agreed at the 1994
international conference on population and develop›
ment.11 However, the concept of reproductive health
covers a wide range of issues, and the strong focus
needed to improve maternity care may be lost in an
integrated approach, especially when it is expressed in
the language of primary health care.12 This loss of
focus may be exacerbated by the fact that many agen›
cies and groups involved in reproductive health care
originally worked in family planning, and strategies for
providing family planning services (for example subsi›
dising the marketing of contraceptives) differ from
those needed for providing essential obstetric care.
Another emerging issue for donors is whether the
concept of reproductive health can be strengthened
without creating a vast vertically funded structure,
albeit one that replaces several others.
Adequate financing
Health services
Appropriate policies
Evidence based guidelines
Skilled staff providing 
  24 hour cover
Supportive management
Appropriate infrastructure
  and equipment
Supplies of drugs and blood
Reliable logistical support
Monitoring
Community services
Information and
  education to
  promote health
  seeking behaviour
Referral services
Transport
Communications
Improved availability,
accessibility, use,
and quality of care
Reduction in
maternal deaths
Fig 1 Resources needed to improve essential obstetric care
Approaches to funding improvements in maternal health
Vertical project
Reproductive health
programme Sector›wide approach
Technical scope Focuses exclusively on maternal
health
Focuses on a wide range of
reproductive health issues
including family planning,
adolescent health, reproductive
rights, sexually transmitted
diseases, and maternal health
Focuses on all essential
components of health service
including maternal health
Management Project managed separately within
ministry of health
Programme managed separately
within ministry of health
Management of integrated services
decentralised to district level
Personnel Project funds key individuals to
manage activities
Programme funds key individuals
to manage activities
Changes in remuneration made as
part of financial planning and
human resources development
Training Courses centrally planned and
funded
Courses centrally planned and
funded
Maternal health topics covered by
in›service training plans for district
Supplies and
monitoring
Separate systems for logistics and
information
Separate systems for logistics and
information
Integrated logistics and health
information systems
Transport Vehicles only used by project Vehicles only used by programme Vehicles used for variety of
purposes
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Health programmes supported by the United
Nations Population Fund typically adopt a reproduc›
tive health strategy. In some countries, such as
Morocco, Mozambique, and Bangladesh, reproductive
health programmes include a large essential obstetric
care component. However, this is not always the case.
In a reproductive health initiative supported by the
United Nations Population Fund and the European
Commission, which involves seven Asian countries,
only 11 out of 40 projects mention any aspect of
maternal health.13
Sector›wide approaches
Sector›wide approaches and other comprehensive
frameworks were developed and applied to health care
because they were thought to offer better prospects for
success than piecemeal projects financed separately.14
They also have the potential to eliminate the
duplication of activities14 and the distortions created
within health systems by vertically funded, single issue
programmes. Sector›wide approaches present a good
opportunity for donors to support policies that will
lead to the development of effective and efficient health
systems.
Opportunities for promoting safe motherhood programmes
There seem to be no donor supported, sector›wide
approaches that have emphasised safe motherhood as
an indicator condition or goal. In contrast, health
sector assistance strategies have been known to omit
maternal mortality as an issue, even in countries where
there are serious maternal health problems.10
Nevertheless, there are two main reasons for
promoting safe motherhood through sector›wide
approaches.
Firstly, donors invest considerable resources in
both health services and the health sector generally. In
1990, it was estimated that 46% of external assistance
to the health and population sectors was allocated to
general health services (of which 5% was spent on hos›
pitals) and 46% to reproductive health. Within
reproductive health care, the proportion spent on ver›
tical safe motherhood programmes was 0.2%; 41.9%
was spent on family planning and population issues.15
For this reason, it may make better tactical sense for
maternal health programmes to be linked with and tap
into the greater funds available for health sector devel›
opment rather than to compete with a large, articulate
constituency for family planning funds.
Secondly, the dependence of initiatives for promot›
ing safe motherhood on health systems means that
health sector reforms have huge implications for these
programmes. For example, the introduction of user
fees has been associated with a reduced use of
maternity care in some situations (for example, in
Kenya and Zimbabwe) and an increase in others (for
example, in Cambodia).10 16 Many proposed solutions,
such as insurance schemes, fail to cover precisely those
interventions that could save lives. For example, in
Yunnan, China, an insurance scheme covered ante›
natal and postnatal care but not delivery.17 Linking safe
motherhood programmes to sector›wide approaches
at an early stage may mean that the implications of
proposed solutions to providing better care can be
tested and considered.
Of course there are several areas of concern for
advocates of safe motherhood. A reliance on
sector›wide approaches might mean that crucial areas
of care are not supported. Donor agencies that support
sector›wide approaches need to be aware that some
key activities that are essential to improving maternity
care might not be covered by broad approaches to
funding. These include reviewing and updating obstet›
ric protocols and curriculums; training trainers in spe›
cific techniques, such as manual vacuum aspiration;
updating maternity recording systems; and initiating
obstetric audits and other quality control measures. It is
also important to support the training and use of mid›
wives with a view towards increasing the availability of
skilled personnel, particularly if the goal of having
skilled attendants present at all births is adopted.18
These and related activities need focused technical
assistance and funding.
Benefits of focusing on safe motherhood initiatives
Advocates of sector›wide approaches may be con›
cerned that linking resources to indicators associated
with safe motherhood is a covert tactic in a move
towards verticalisation. In reality it can be seen as an
opportunity to test the robustness of sector›wide
approaches against a few agreed health priorities. The
link need not focus on safe motherhood alone but
could be broadened to include clinical conditions, such
as tuberculosis, HIV/AIDS, and malaria, that have been
recognised as global priorities.19 Linking safe mother›
hood to sector›wide approaches can help counter
donors’ fears that they are being asked to contribute to
a bottomless pit within the health sector and can pro›
mote a process of evaluation that measures outcomes,
something which has so far been lacking.20
Conclusion
In the long term, sustaining affordable improvements
in safe motherhood depends on improving the
functioning of health systems as a whole. Gains made
in countries such as Malaysia and Sri Lanka were
achieved by making maternity care a priority that
guided changes in health services. Efforts to achieve
similar gains in other developing countries need prag›
matic support. Sector›wide approaches and other
Moroccan women benefit from reproductive health programmes that have a large component
of essential obstetric care
AB
D
EL
M
AK
SE
NN
A/
AF
P
Education and debate
919BMJ VOLUME 322 14 APRIL 2001 bmj.com
routes to health system reform, intended to offer alter›
natives to failing public systems and provide improved
health services in a spirit of equity, are compatible with
a focus on maternal health services. If performance, as
measured by indicators of safe motherhood as well as
other essential health indicators, was a condition of
funding, the placing of maternal health services at the
centre of the sector could be assured. In political envi›
ronments in which partnerships between donors and
governments are likely to succeed, sector›wide
approaches present a unique opportunity for advo›
cates of safe motherhood to make a sustainable impact
on maternal mortality.
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Call for a new approach to the process of clinical trials
and drug registration
Thomas C Jones
The process of phases I›IV of clinical trials is the
cornerstone of the drug registration and regulation
process.1 Yet expanding drug expenses, the slow proc›
ess of development in critical areas of need, poor
worldwide distribution of new therapeutics, and an
emerging multibillion dollar industry receiving
finances for clinical trials as a part of healthcare deliv›
ery, indicate that the process needs revision. Recent
changes in testing by clinical trials, different methods
of supervision of drug development by pharmaceutical
companies, and new methods for the monitoring of
drug safety suggest a direction for this revision. A fresh
approach is proposed (see boxes, p 921). This article
reviews the basis for considering this new approach.
Recent changes in the process of phases
I›IV of drug development
The initial goal of clinical trials for drug registration was
that a new drug treatment must be safer and more effec›
tive than no treatment for a specific disease. A plan to
achieve this goal was outlined in the United States by the
Kefauver›Harris Drug Amendments, approved in 1962.2
The box on p 922 describes phases I›IV that have
evolved.1 This has become the central part of drug regis›
tration both by the Food and Drug Administration in
the United States3 and by the European Commission.4
Summary points
The process of phases I›IV of clinical trials for
drug registration is expensive, raises ethical issues
of informed consent in phases III and IV, and has
been expanded to try to answer too many
questions
Careful assessment of recent, well constructed
safety data from phase II studies compared with
data from the end of phase III is expected to show
little new safety information gained from phase III
A fresh approach to drug registration is needed
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